infectious diseases

News

Novartis says novel drug could counter malaria resistance

Novartis has reported what looks like another big step forward in the treatment of malaria, as a drug with a novel mechanism hits the mark in phase 3.

News

Pregnant woman puts her hands over her growing belly in shape of a heart

Moderna drops mRNA jab for CMV after phase 3 fail

Moderna has decided to halt the development of its mRNA-1647 vaccine for congenital CMV infections, once touted as a future blockbuster.

News

Enanta weakens on RSV treatment trial readout

Shares in Enanta Pharma were sliding this morning after it reported results of a phase 2b trial of its RSV antiviral zelicapavir.

News

Dynavax has GSK's shingles vaccine in its sights

Big pharma group GSK has been ruling the market for shingles vaccines for many years, but little Dynavax wants to knock off its crown.

News

Iterum brings first oral penem antibiotic to US market

Iterum has launched Orlynvah as a treatment for uncomplicated urinary tract infections (uUTIs), the first oral option in the go-to penem class.

News

RFK Jr revives childhood vaccine task force

HHS Secretary Kennedy adds yet another layer of scrutiny to childhood vaccines with the re-establishment of a task force disbanded in the 1990s.

Novartis says novel drug could counter malaria resistance

Moderna drops mRNA jab for CMV after phase 3 fail

Enanta weakens on RSV treatment trial readout

Dynavax has GSK's shingles vaccine in its sights

Iterum brings first oral penem antibiotic to US market

RFK Jr revives childhood vaccine task force

LSX2026: On promise and patience, with Hans Schambye

Using AI-driven synthetic personas to take your insights fur...

infectious diseases

Editor's Picks